Technical Analysis for KYMR - Kymera Therapeutics, Inc.

Grade Last Price % Change Price Change
F 33.44 -4.43% -1.55
KYMR closed down 4.43 percent on Friday, April 9, 2021, on 68 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical KYMR trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -4.43%
NR7 Range Contraction -4.43%
Wide Bands Range Expansion -4.43%
Down 3 Days in a Row Weakness -4.43%
Older End-of-Day Signals for KYMR ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits about 7 hours ago
Down 5% 1 day ago
60 Minute Opening Range Breakdown 1 day ago
Down 3% 1 day ago
Down 2 % 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa, atopic dermatitis, and rheumatoid arthritis; IRAKIMiD program to treat MYD88-mutated diffuse large B cell lymphoma; and STAT3 program for the treatment of hematologic malignancies and solid tumors, as well as autoimmune diseases. The company was founded in 2015 and is headquartered in Watertown, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Immunology Solid Tumors Immune System Autoimmune Diseases Rheumatoid Arthritis Autoimmunity Hematologic Malignancies Dermatitis Atopic Dermatitis Hidradenitis Suppurativa

Is KYMR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 91.92
52 Week Low 25.43
Average Volume 369,150
200-Day Moving Average 0.00
50-Day Moving Average 52.35
20-Day Moving Average 43.20
10-Day Moving Average 36.51
Average True Range 3.96
ADX 35.33
+DI 12.20
-DI 33.01
Chandelier Exit (Long, 3 ATRs ) 48.97
Chandelier Exit (Short, 3 ATRs ) 44.76
Upper Bollinger Band 60.18
Lower Bollinger Band 26.22
Percent B (%b) 0.21
BandWidth 78.61
MACD Line -5.40
MACD Signal Line -5.10
MACD Histogram -0.3011
Fundamentals Value
Market Cap 1.49 Billion
Num Shares 44.5 Million
EPS
Price-to-Sales 88.83
Price-to-Book 6.96
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.04
Resistance 3 (R3) 36.14 35.37 35.60
Resistance 2 (R2) 35.37 34.71 35.32 35.46
Resistance 1 (R1) 34.41 34.30 34.03 34.31 35.31
Pivot Point 33.64 33.64 33.45 33.59 33.64
Support 1 (S1) 32.68 32.98 32.30 32.58 31.57
Support 2 (S2) 31.91 32.57 31.86 31.42
Support 3 (S3) 30.95 31.91 31.28
Support 4 (S4) 30.85